30 employees
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
2014
$75M
from 3 investors over 3 rounds
Corvus Pharmaceuticals raised $75M on September 25, 2015
Investors: OrbiMed Advisors and Adams Street Partners
Corvus Pharmaceuticals raised $34M on December 1, 2014
Investors: OrbiMed Advisors